190 related articles for article (PubMed ID: 17636069)
1. Endocannabinoids in basal ganglia circuits: implications for Parkinson disease.
Benarroch E
Neurology; 2007 Jul; 69(3):306-9. PubMed ID: 17636069
[No Abstract] [Full Text] [Related]
2. Basal ganglia oscillations and pathophysiology of movement disorders.
Rivlin-Etzion M; Marmor O; Heimer G; Raz A; Nini A; Bergman H
Curr Opin Neurobiol; 2006 Dec; 16(6):629-37. PubMed ID: 17084615
[TBL] [Abstract][Full Text] [Related]
3. Homeostatic changes of the endocannabinoid system in Parkinson's disease.
Pisani V; Madeo G; Tassone A; Sciamanna G; Maccarrone M; Stanzione P; Pisani A
Mov Disord; 2011 Feb; 26(2):216-22. PubMed ID: 21412829
[TBL] [Abstract][Full Text] [Related]
4. The endocannabinoid system in neuropathological states.
Orgado JM; Fernández-Ruiz J; Romero J
Int Rev Psychiatry; 2009 Apr; 21(2):172-80. PubMed ID: 19367511
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
Pierucci M; Galati S; Valentino M; Di Matteo V; Benigno A; Pitruzzella A; Muscat R; Di Giovanni G
CNS Neurol Disord Drug Targets; 2011 Nov; 10(7):777-91. PubMed ID: 21999732
[TBL] [Abstract][Full Text] [Related]
6. Endocannabinoids and liver disease. I. Endocannabinoids and their receptors in the liver.
Mallat A; Lotersztajn S
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G9-G12. PubMed ID: 17975129
[TBL] [Abstract][Full Text] [Related]
7. Marijuana researchers reach for pot of gold.
Mandavilli A
Nat Med; 2003 Oct; 9(10):1227. PubMed ID: 14520348
[No Abstract] [Full Text] [Related]
8. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
Ligresti A; Petrosino S; Di Marzo V
Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
[TBL] [Abstract][Full Text] [Related]
9. Parkinson's disease related alterations in cannabinoid transmission.
Soti M; Ranjbar H; Kohlmeier KA; Shabani M
Brain Res Bull; 2022 Jan; 178():82-96. PubMed ID: 34808322
[TBL] [Abstract][Full Text] [Related]
10. CB1 cannabinoid receptor signalling in Parkinson's disease.
Brotchie JM
Curr Opin Pharmacol; 2003 Feb; 3(1):54-61. PubMed ID: 12550742
[TBL] [Abstract][Full Text] [Related]
11. The control of seizures by the basal ganglia? A review of experimental data.
Deransart C; Depaulis A
Epileptic Disord; 2002 Dec; 4 Suppl 3():S61-72. PubMed ID: 12495876
[TBL] [Abstract][Full Text] [Related]
12. New insights on endocannabinoid transmission in psychomotor disorders.
Giuffrida A; Seillier A
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):51-8. PubMed ID: 22521335
[TBL] [Abstract][Full Text] [Related]
13. [Cerebral hemodynamics and clinical pharmacology in Parkinson disease].
Marc-Vergnes JP; Celsis P; Montastruc JL; Demonet JF; Agniel A; Rascol O; Viallard G; Doyon B; Rascol A
Therapie; 1988; 43(2):83-8. PubMed ID: 3406932
[No Abstract] [Full Text] [Related]
14. Distinctive Evidence Involved in the Role of Endocannabinoid Signalling in Parkinson's Disease: A Perspective on Associated Therapeutic Interventions.
Behl T; Kaur G; Bungau S; Jhanji R; Kumar A; Mehta V; Zengin G; Brata R; Hassan SSU; Fratila O
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872273
[TBL] [Abstract][Full Text] [Related]
15. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
[TBL] [Abstract][Full Text] [Related]
16. Serotonergic modulation of basal ganglia circuits: complexity and therapeutic opportunities.
Benarroch EE
Neurology; 2009 Sep; 73(11):880-6. PubMed ID: 19752456
[No Abstract] [Full Text] [Related]
17. Synaptic plasticity, dopamine and Parkinson's disease: one step ahead.
Calabresi P; Mercuri NB; Di Filippo M
Brain; 2009 Feb; 132(Pt 2):285-7. PubMed ID: 19168452
[No Abstract] [Full Text] [Related]
18. Endocannabinoids and reproductive endocrinology.
Maccarrone M
Curr Opin Investig Drugs; 2009 Apr; 10(4):305-10. PubMed ID: 19337950
[TBL] [Abstract][Full Text] [Related]
19. Circuits and circuit disorders of the basal ganglia.
DeLong MR; Wichmann T
Arch Neurol; 2007 Jan; 64(1):20-4. PubMed ID: 17210805
[TBL] [Abstract][Full Text] [Related]
20. [Endocannabinoids multifunctional messenger system in control of pleasure and eating habit].
Savolainen MJ; Huusko T; Keränen AM; Lindeman S; Reponen A; Koponen H
Duodecim; 2004; 120(12):1457-65. PubMed ID: 15293706
[No Abstract] [Full Text] [Related]
[Next] [New Search]
